Page 1005 of 1,034: studies 10,041 to 10,050 of 10,336, newest first. Back to the depression overview
Holistic Nursing Practice 2003 Ramita Bonadonna 146 citations
Meditation is becoming widely popular as an adjunct to conventional medical therapies. This article reviews the literature regarding the experience of chronic illness, theories about meditation, and clinical effects of this self-care practice. Eastern theories of meditation include Buddhist psychology. The word Buddha means the awakened one, and Buddhist meditators have been called the first...
Brain Research November 22, 2002 Suzanne Colbron, Mark Jones, Stephany M Biello
3,4-Methylenedioxymethamphetamine (MDMA or 'Ecstasy') is a widely used recreational drug that damages serotonin 5-HT neurons in animals and possibly humans. Published literature has shown that the serotonergic system is involved in photic and non-photic phase shifting of the circadian clock, which is located in the suprachiasmatic nuclei. Despite the dense innervation of the circadian system by...
The Journal of Clinical Pharmacology November 2002 Margaret Haney
This article presents data from two avenues of marijuana research. First, the author shows that daily marijuana smoking in healthy individuals produces dependence, as demonstrated by withdrawal symptoms such as increased irritability and depression and decreased food intake. In addition, two antidepressant medications were evaluated to assess their potential effectiveness in the treatment of...
Human Psychopharmacology: Clinical and Experimental July 12, 2002 A. C. Parrott, Tom Buchanan, Andrew Scholey et al. 163 citations
Abstract Rationale The recreational use of MDMA/Ecstasy (3,4‐methylenedioxymethamphetamine) is associated with many psychobiological problems, but there is a paucity of data on how these relate to the level of past use. Objectives: to assess the incidence of Ecstasy‐attributed problems as reported by novice, moderate and heavy users. Methods: 763 unpaid volunteers took part in a WWW study of...
Culture, medicine and psychiatry June 2002 Steven A. Friedman, Cheryl M. Paradis
While attention has been paid to the study of panic disorder (PD) with or without agoraphobia among Caucasians, surprisingly little empirical research within the United States has looked at the phenomenology of PD among minority groups. In this paper we present data we have collected and review other research on the phenomenology, social supports, and coping behavior among African-Americans...
Brain research. Cognitive brain research April 2002 Troels W Kjaer, Camilla Bertelsen, Paola Piccini et al.
This is the first in vivo demonstration of an association between endogenous neurotransmitter release and conscious experience. Using 11C-raclopride PET we demonstrated increased endogenous dopamine release in the ventral striatum during Yoga Nidra meditation. Yoga Nidra is characterized by a depressed level of desire for action, associated with decreased blood flow in prefrontal, cerebellar...
Psychopharmacology April 1, 2002 Suzanne L. Verheyden, J. A. Hadfield, Tara Calin et al. 118 citations
RationaleResearch with animals suggests that central 5-hydroxytryptamine (5-HT) function may be attenuated for a period following a single dose of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). If the same is true in humans, then functions thought to be modulated by 5-HT may differ in MDMA users compared with non-users a few days after the drug is taken.AimsThe present study therefore...
March 1, 2002 P. Mcnamara
I hypothesize that people engage in religious practices, in part, because such practices activate the frontal lobes. Activation of the frontal lobes is both intrinsically rewarding and necessary for acquisition of many of the behaviors that religions seek to foster, including self-responsibility, impulse and emotion modulation, empathy, moral insight, hope, and optimism. Although direct tests...
Clinical Psychology & Psychotherapy March 1, 2002 Zindel V. Segal, John D. Teasdale, Jane Williams et al. 420 citations
Abstract The development of the Mindfulness‐Based Cognitive Therapy Adherence Scale (MBCT‐AS) is described. This 17‐item scale measures therapist adherence to the treatment protocol for Mindfulness‐Based Cognitive Therapy (MBCT), a treatment for the prevention of recurrence in Major Depressive Disorder. The MBCT‐AS assesses therapist behaviours specific to (MBCT) as well as therapy practices...
Psychopathology 2002 Carlo Maggini, Andrea Raballo, Paola Salvatore
The purpose of this study is to examine the classic psychopathologic notion of depersonalization in the light of the Basic Symptom paradigm. A sample of 57 chronic schizophrenics was cross-sectionally assessed with the Bonn Scale for the Assessment of Basic Symptoms (BSABS) and contextually with specific scales testing positive, negative, depressive and alexithymic dimensions. In order to...